Medicine and Dentistry
Mitogen-Activated Protein Kinase
100%
Drug Resistance
100%
Drug
50%
Chemotherapeutic Agent
50%
Development
33%
Combination Therapy
33%
Family
33%
Next Generation Sequencing
33%
Nodular Melanoma
16%
Neoplasm
16%
Comprehension
16%
Mortality Rate
16%
Malignant Neoplasm
16%
Receptor
16%
Membrane Protein
16%
Ligation
16%
Solid Malignant Neoplasm
16%
Cancer Types
16%
Colorectal Cancer
16%
Overall Survival
16%
Progression Free Survival
16%
Hematologic Malignancy
16%
Salicylate Sodium
16%
Specific Tumor
16%
Aberration
16%
Protein Tyrosine Kinase
16%
Kinase Signaling
16%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Resistance
100%
Mitogen Activated Protein Kinase
100%
Clinical Trial
100%
Drug
50%
Malignant Neoplasm
33%
Neoplasm
33%
Drug Delivery System
33%
Combination Therapy
33%
Receptor
16%
Mortality Rate
16%
Protein Tyrosine Kinase
16%
Melanoma
16%
Membrane Protein
16%
Hematologic Malignancy
16%
Overall Survival
16%
Salicylate Sodium
16%
Colorectal Cancer
16%
Progression Free Survival
16%
Solid Malignant Neoplasm
16%
Biochemistry, Genetics and Molecular Biology
Mutation
100%
Mitogen-Activated Protein Kinase
100%
Drug Resistance
100%
Development
33%
Comprehension
16%
Time
16%
Receptor Tyrosine Kinase
16%
Isoform
16%
Mortality Rate
16%
Solid
16%
Genetic Architecture
16%
Overall Survival
16%
Drug Targeting
16%
Progression Free Survival
16%
Transmembrane Protein
16%